Diflucan snagged as China tightens imported drug oversight
This article was originally published in Scrip
Executive Summary
Despite its long-term market experience in China, Pfizer's first lesson of 2014 in the country is ironically all about compliance with local regulations. The US giant's antifungal drug Diflucan (fluconazole injection) has been suspended from entering the country by China's Food and Drug Administration (CFDA).